Roivant Sciences's total assets for Q1 2025 were $5.03B, a decrease of -7.44% from the previous quarter. ROIV total liabilities were $216.70M for the fiscal quarter, a -13.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.